Menekse, E. Et Al. 2022. Indoleamine-2,3-dioxygenase-related anti-inflammatory effects of 3-aminobenzamide and infliximab in experimental colitis. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , vol.68, no.3 , 362-366.

Menekse, E., Aydin, S., Aydin, O. U., Sahin, D., Akca, G., Eroglu, A., ... Sepici Dinçel, A.(2022). Indoleamine-2,3-dioxygenase-related anti-inflammatory effects of 3-aminobenzamide and infliximab in experimental colitis. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , vol.68, no.3, 362-366.

Menekse, Ebru Et Al. "Indoleamine-2,3-dioxygenase-related anti-inflammatory effects of 3-aminobenzamide and infliximab in experimental colitis," REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , vol.68, no.3, 362-366, 2022

Menekse, Ebru Et Al. "Indoleamine-2,3-dioxygenase-related anti-inflammatory effects of 3-aminobenzamide and infliximab in experimental colitis." REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , vol.68, no.3, pp.362-366, 2022

Menekse, E. Et Al. (2022) . "Indoleamine-2,3-dioxygenase-related anti-inflammatory effects of 3-aminobenzamide and infliximab in experimental colitis." REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , vol.68, no.3, pp.362-366.

@article{article, author={Ebru Menekse Et Al. }, title={Indoleamine-2,3-dioxygenase-related anti-inflammatory effects of 3-aminobenzamide and infliximab in experimental colitis}, journal={REVISTA DA ASSOCIACAO MEDICA BRASILEIRA}, year=2022, pages={362-366} }